Advanced non-small cell lung cancer in the elderly: The impact of age and comorbidities on treatment modalities and patient prognosis

Journal of Geriatric Oncology

Volumn 6, Issue 1, 2015, Pages 38-45

  Hsu, Chia Lin ^a,b   Chen, Jen Hau ^a   Chen, Kuan Yu ^a   Shih, Jin Yuan ^a   Yang, James Chih Hsin ^a   Yu, Chong Jen ^a   Yang, Pan Chyr ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Chemotherapy; EGFR TKI; Elderly; Lung cancer; Prognosis; Survival

Indexed keywords

AFATINIB; CARBOPLATIN; CISPLATIN; DOCETAXEL; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; ERLOTINIB; FLUOROURACIL; GEFITINIB; GEMCITABINE; NAVELBINE; PACLITAXEL; PLATINUM COMPLEX; PROTEIN KINASE INHIBITOR;

ADENOCARCINOMA; ADVANCED CANCER; AGE; AGED; ALCOHOLISM; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER INCIDENCE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; CHARLSON COMORBIDITY INDEX; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONTROLLED STUDY; CYTOLOGY; DIABETES MELLITUS; EGFR GENE; FEMALE; GENE MUTATION; HEALTH STATUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERTENSION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MONOTHERAPY; MULTIVARIATE ANALYSIS; NON SMALL CELL LUNG CANCER; OVERALL SURVIVAL; RESPIRATORY TRACT DISEASE; SEX DIFFERENCE; SIMPLIFIED COMORBIDITY SCORE; SINGLE DRUG DOSE; SMOKING; SOCIAL SUPPORT; SQUAMOUS CELL CARCINOMA; SURVIVAL TIME; UNDIFFERENTIATED CARCINOMA; UNIVARIATE ANALYSIS; VERY ELDERLY; ANTAGONISTS AND INHIBITORS; CARCINOMA, NON-SMALL-CELL LUNG; LUNG NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; TAIWAN;

AGE FACTORS; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; COMORBIDITY; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; PROGNOSIS; PROTEIN KINASE INHIBITORS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RETROSPECTIVE STUDIES; RISK FACTORS; SMOKING; TAIWAN;

EID: 84920872437     PISSN: 18794068     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jgo.2014.09.178     Document Type: Article

References (41)

1. Siegel R., Naishadham D., Jemal A. Cancer statistics, 2012. CA: a cancer journal for clinicians 2012 , 62(1):10-29. [PubMed PMID: 22237781].
2. Smith B.D., Smith G.L., Hurria A., Hortobagyi G.N., Buchholz T.A. Future of cancer incidence in the United States: burdens upon an aging, changing nation. J Clin Oncol 2009, 27(17):2758-2765. [PubMed PMID: 19403886].
3. SEER Cancer Statistics Review (Vintage 2009 populations) [Internet]. National Cancer Institute. 2012 [cited 28. January 2013.] [Available from]. http://seer.cancer.gov/csr/1975_2009_pops09/.
4. Cancer Registry Annual Report 2009 Taiwan [Internet]. Bureau of Health Promotion. Feburay. 2012 [cited 28. January. 2013] [Available from]. http://www.bhp.doh.gov.tw/BHPNet/Web/Stat/StatisticsShow.aspx?No=201206210001.
5. Hutchins L.F., Unger J.M., Crowley J.J., Coltman C.A., Albain K.S. Underrepresentation of patients 65years of age or older in cancer-treatment trials. N Engl J Med 1999, 341(27):2061-2067. [PubMed PMID: 10615079].
6. Murthy V.H., Krumholz H.M., Gross C.P. Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA 2004, 291(22):2720-2726. [PubMed PMID: 15187053].
7. Jatoi A., Hillman S., Stella P., Green E., Adjei A., Nair S., et al. Should elderly non-small-cell lung cancer patients be offered elderly-specific trials? Results of a pooled analysis from the North Central Cancer Treatment Group. J Clin Oncol 2005, 23(36):9113-9119. [PubMed PMID: 16361618].
8. Hurria A., Kris M.G. Management of lung cancer in older adults. CA: a cancer journal for clinicians 2003 , 53(6):325-341. [PubMed PMID: 15224973].
9. The Elderly Lung Cancer Vinorelbine Italian Study Group Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small-cell lung cancer. J Natl Cancer Inst 1999, 91(1):66-72. [PubMed PMID: 9890172].
10. Costa G.J., Fernandes A.L., Pereira J.R., Curtis J.R., Santoro I.L. Survival rates and tolerability of platinum-based chemotherapy regimens for elderly patients with non-small-cell lung cancer (NSCLC). Lung Cancer 2006 Aug, 53(2):171-176. [PubMed PMID: 16757059].
11. Rocha Lima C.M., Herndon J.E., Kosty M., Clamon G., Green M.R. Therapy choices among older patients with lung carcinoma: an evaluation of two trials of the cancer and leukemia group B. Cancer 2002, 94(1):181-187. [PubMed PMID: 11815975].
12. Langer C.J., Manola J., Bernardo P., Kugler J.W., Bonomi P., Cella D., et al. Cisplatin-based therapy for elderly patients with advanced non-small-cell lung cancer: implications of Eastern Cooperative Oncology Group 5592, a randomized trial. J Natl Cancer Inst 2002, 94(3):173-181. [PubMed PMID: 11830607].
13. Quoix E., Zalcman G., Oster J.P., Westeel V., Pichon E., Lavole A., et al. Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial. Lancet 2011, 378(9796):1079-1088. [PubMed PMID: 21831418].
14. Owonikoko T.K., Ragin C.C., Belani C.P., Oton A.B., Gooding W.E., Taioli E., et al. Lung cancer in elderly patients: an analysis of the surveillance, epidemiology, and end results database. J Clin Oncol 2007, 25(35):5570-5577. [PubMed PMID: 18065729].
15. Janssen-Heijnen M.L., Smulders S., Lemmens V.E., Smeenk F.W., van Geffen H.J., Coebergh J.W. Effect of comorbidity on the treatment and prognosis of elderly patients with non-small cell lung cancer. Thorax 2004 Jul, 59(7):602-607. [PubMed PMID: 15223870. Pubmed Central PMCID: 1747080].
16. Wang S., Wong M.L., Hamilton N., Davoren J.B., Jahan T.M., Walter L.C. Impact of age and comorbidity on non-small-cell lung cancer treatment in older veterans. J Clin Oncol 2012, 30(13):1447-1455. [PubMed PMID: 22454424. Pubmed Central PMCID: 3383118].
17. McLean A.J., Le Couteur D.G. Aging biology and geriatric clinical pharmacology. Pharmacol Rev 2004 , 56(2):163-184. [PubMed PMID: 15169926].
18. Wells C.K., Stoller J.K., Feinstein A.R., Horwitz R.I. Comorbid and clinical determinants of prognosis in endometrial cancer. Arch Intern Med 1984 , 144(10):2004-2009. [PubMed PMID: 6385896].
19. Feinstein A.R., Wells C.K. A clinical-severity staging system for patients with lung cancer. Medicine 1990 , 69(1):1-33. [PubMed PMID: 2299974].
20. Piccirillo J.F., Feinstein A.R. Clinical symptoms and comorbidity: significance for the prognostic classification of cancer. Cancer 19961, 77(5):834-842. [PubMed PMID: 8608472].
21. Firat S., Bousamra M., Gore E., Byhardt R.W. Comorbidity and KPS are independent prognostic factors in stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2002, 52(4):1047-1057. [PubMed PMID: 11958901].
22. Firat S., Byhardt R.W., Gore E. Comorbidity and Karnofksy performance score are independent prognostic factors in stage III non-small-cell lung cancer: an institutional analysis of patients treated on four RTOG studies. Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 2002, 54(2):357-364.
23. Satariano W.A., Ragland D.R. The effect of comorbidity on 3-year survival of women with primary breast cancer. Ann Intern Med 1994, 120(2):104-110. [PubMed PMID: 8256968].
24. Janssen-Heijnen M.L., Maas H.A., Houterman S., Lemmens V.E., Rutten H.J., Coebergh J.W. Comorbidity in older surgical cancer patients: influence on patient care and outcome. Eur J Cancer Oct, 43(15):2179-2193. [PubMed PMID: 17681780].
25. Okami J., Higashiyama M., Asamura H., Goya T., Koshiishi Y., Sohara Y., et al. Pulmonary resection in patients aged 80years or over with clinical stage I non-small cell lung cancer: prognostic factors for overall survival and risk factors for postoperative complications. J Thorac Oncol 2009 , 4(10):1247-1253. [PubMed PMID: 19609223].
26. Takenaka T., Katsura M., Shikada Y., Tsukamoto S., Takeo S. The impact of cardiovascular comorbidities on the outcome of surgery for non-small-cell lung cancer. Interact Cardiovasc Thorac Surg 2013, 16(3):270-274. [PubMed PMID: 23223675].
27. Asmis T.R., Ding K., Seymour L., Shepherd F.A., Leighl N.B., Winton T.L., et al. Age and comorbidity as independent prognostic factors in the treatment of non small-cell lung cancer: a review of National Cancer Institute of Canada Clinical Trials Group trials. J Clin Oncol 2008, 26(1):54-59. [PubMed PMID: 18165640].
28. Colinet B., Jacot W., Bertrand D., Lacombe S., Bozonnat M.C., Daures J.P., et al. A new simplified comorbidity score as a prognostic factor in non-small-cell lung cancer patients: description and comparison with the Charlson's index. Br J Cancer 2005, 93(10):1098-1105. [PubMed PMID: 16234816. Pubmed Central PMCID: 2361505].
29. Kuo Y.W., Jerng J.S., Shih J.Y., Chen K.Y., Yu C.J., Yang P.C. The prognostic value of the simplified comorbidity score in the treatment of small cell lung carcinoma. J Thorac Oncol 2011 , 6(2):378-383. [PubMed PMID: 21173715].
30. Jacot W., Colinet B., Bertrand D., Lacombe S., Bozonnat M.C., Daures J.P., et al. Quality of life and comorbidity score as prognostic determinants in non-small-cell lung cancer patients. Ann Oncol 2008 , 19(8):1458-1464. [PubMed PMID: 18356134].
31. Read W.L., Tierney R.M., Page N.C., Costas I., Govindan R., Spitznagel E.L., et al. Differential prognostic impact of comorbidity. J Clin Oncol 2004, 22(15):3099-3103. [PubMed PMID: 15284260].
32. Mountain C.F. Revisions in the international system for staging lung cancer. Chest 1997 , 111(6):1710-1717. [PubMed PMID: 9187198].
33. The World Health Organization histological typing of lung tumours. Second edition. Am J Clin Pathol 1982 , 77(2):123-136. [PubMed PMID: 7064914].
34. Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40(5):373-383. [PubMed PMID: 3558716].
35. Sardari Nia P., Weyler J., Colpaert C., Vermeulen P., Van Marck E., Van Schil P. Prognostic value of smoking status in operated non-small cell lung cancer. Lung Cancer 2005 Mar, 47(3):351-359. [PubMed PMID: 15713518].
36. Nordquist L.T., Simon G.R., Cantor A., Alberts W.M., Bepler G. Improved survival in never-smokers vs current smokers with primary adenocarcinoma of the lung. Chest 2004 Aug, 126(2):347-351. [PubMed PMID: 15302716].
37. Tsao A.S., Liu D., Lee J.J., Spitz M., Hong W.K. Smoking affects treatment outcome in patients with advanced nonsmall cell lung cancer. Cancer Jun 1 2006, 106(11):2428-2436. [PubMed PMID: 16634096].
38. Janjigian Y.Y., McDonnell K., Kris M.G., Shen R., Sima C.S., Bach P.B., et al. Pack-years of cigarette smoking as a prognostic factor in patients with stage IIIB/IV nonsmall cell lung cancer. Cancer Feb 1 2010, 116(3):670-675. [PubMed PMID: 20029977. Pubmed Central PMCID: 2815173].
39. Ferketich A.K., Niland J.C., Mamet R., Zornosa C., D'Amico T.A., Ettinger D.S., et al. Smoking status and survival in the national comprehensive cancer network non-small cell lung cancer cohort. Cancer Feb, 2013, 119(4):847-853. [PubMed PMID: 23023590].
40. Girones R., Torregrosa D., Gomez-Codina J., Maestu I., Tenias J.M., Rosell R. Prognostic impact of comorbidity in elderly lung cancer patients: use and comparison of two scores. Lung Cancer 2011 Apr, 72(1):108-113. [PubMed PMID: 20727613].
41. Maestu I., Munoz J., Gomez-Aldaravi L., Esquerdo G., Yubero A., Torregrosa M.D., et al. Assessment of functional status, symptoms and comorbidity in elderly patients with advanced non-small-cell lung cancer (NSCLC) treated with gemcitabine and vinorelbine. Clin Transl Oncol 2007 Feb, 9(2):99-105. [PubMed PMID: 17329221].